Status: Not yet recruiting
Assessing Safety of Cervical Spine Fusion With NMP®
The goal of this retrospective chart review study is to assess safety of NMP® in the treatment of cervical spine degenerative conditions by assessing the incidence and nature of AEs in follow-up (minimum of 90 days and up to 2 year post-operatively) as well as reoperation rates.
Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Red Rock Regeneration Inc.Updated: Nov 24, 2025Locations: 1
Eligibility criteria
Patients treated with NMP® for Cervical (C2-T1) Interbody fusion (2022-2025) at... [+1]
Patients with no follow-up data within 3 months from the surgery date due to mis...